Ryan Moy, MD, PhD

Dr. Moy is a physician-scientist and member of the gastrointestinal oncology and experimental therapeutics/phase 1 programs at Columbia University Irving Medical Center. In addition to leading clinical trials investigating novel precision therapies and immunotherapies, he is performing translational studies utilizing patient samples and preclinical models to decipher key mechanisms driving gastric cancer progression and metastasis. Through this work, he hopes to develop innovative treatment strategies to improve clinical outcomes in patients with advanced gastroesophageal cancer.